Brenda Canine, PhD, received her undergraduate degree in chemical engineering, doctoral degree in pharmacology and conducted postdoctoral work in the field of neurodegeneration at the McLaughlin Research Institute where she and her colleagues published the first manuscript on systems biology in neurodegeneration.

Education

• PhD, Pharmacology/Toxicology (Pharmaceutical Sciences) Protein Polymer Drug Delivery, Washington State University
• BS, Chemical Engineering, University of Idaho

Research

Research interests: metabolic disease and protein folding, mental health and suicide, and understanding Alzheimer’s disease.